Author:
DaCosta J,Hamilton R,Nago J,Mapani A,Kennedy E,Luckett T,Pavesio C,Flanagan D
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. NICE technology appraisal guidance 155; issued August 2008, modified May 2012.
2. Marshall GN, Hays RD The patient satisfaction questionnaire short form (PSQ-18) 1994: RAND.
3. Augood CA, Vingerling JR, de Jong PT, Chakravarthy U, Seland J, Soubrane G et al. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol 2006; 124: 529–535.
4. Bunce C, Wormald R . Leading causes of certification for blindness and partial sight in England & Wales. BMC Public Health 2006; 6: 58.
5. Minassian DC, Reidy A, Lightstone A, Desai P . Modelling the prevalence of age-related macular degeneration (2010-2020) in the UK: expected impact of anti-vascular endothelial growth factor (VEGF) therapy. Br J Ophthalmol 2011; 95: 1433–1436.
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献